{
    "eid": "2-s2.0-85085563803",
    "title": "Role of opioidergic system in regulating depression pathophysiology",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Amygdala",
        "Ceramide",
        "Circadian rhythm",
        "Depression",
        "Endogenous opioids",
        "Gut dysbiosis",
        "Inflammation",
        "LPS",
        "Melatonin",
        "Mitochondria"
    ],
    "authors": [
        "George Anderson",
        "Michael Maes"
    ],
    "citedby-count": 5,
    "ref-count": 205,
    "ref-list": [
        "Epidemiology of suicide: recent developments",
        "Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis",
        "Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment",
        "Intestinal dys-biosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes",
        "Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and ni-trosative stress, with consequences for classification and cognition",
        "An immune gate of depression-Early neuroimmune development in the formation of the underlying depressive disorder",
        "Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications",
        "Increased neural response to social rejection in major depression",
        "Advanced melatonin onset relative to sleep in women with unmedi-cated major depressive disorder",
        "Influence of in utero exposure to maternal depression and natural disaster-related stress on infant temperament at 6 months: The children of superstorm sandy",
        "How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Im-plications",
        "Development of a novel neuro-immune and opioid-associated fingerprint with a cross-validated ability to iden-tify and authenticate unknown patients with major depression: far beyond differentiation, discrimination, and classification",
        "Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome",
        "Depression, pain, and comorbid medical conditions",
        "Mitochondria and immunity in chronic fatigue syndrome",
        "Variation in the \u00b5-opioid receptor gene (OPRM1) and experiences of felt security in response to a romantic partner\u2019s quarrelsome be-havior",
        "Gut-amygdala interactions in autism spectrum disorders: developmental roles via regulating mitochondria, exosomes, immunity and micrornas",
        "Reduced mu opioid receptor availability in schizophrenia revealed with [11C]-carfentanil positron emission tomographic Imaging",
        "Social laughter triggers endogenous opioid release in humans",
        "Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion",
        "Pathoetiology and pathophysiology of borderline personality: Role of prenatal factors, gut microbiome, mu-and kappa-opioid receptors in amygdala-PFC interactions",
        "IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder",
        "Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists",
        "Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders",
        "Enkephalins: Endogenous analgesics with an emerging role in stress resilience",
        "Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches",
        "Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats",
        "Antidepressant-like effects of buprenorphine are mediated by kappa opioid receptors",
        "Kappa-opioid ligands in the study and treatment of mood disorders",
        "A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies",
        "Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2(UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress",
        "Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin",
        "Opiate receptor binding sites in human brain",
        "Regional distribution of opiate receptor binding in monkey and human brain",
        "Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women",
        "Prefrontal expectancy and reinforcement-driven antidepressant placebo effects",
        "Adult attachment style is associated with cerebral \u00b5-opioid receptor availability in humans",
        "Prodynorphin and kappa opioid receptor mRNA expression in the brain relates to social status and behavior in male European starlings",
        "Pain tolerance predicts human social network size",
        "It still hurts: altered endogenous opioid activity in the brain during social rejection and ac-ceptance in major depressive disorder",
        "Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait meas-ures",
        "Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection",
        "beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients",
        "Possible antidepressive effects of opioids: action of buprenorphine",
        "Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: A randomized controlled trial",
        "Results from a long-term open-label extension study of adjunctive buprenor-phine/samidorphan combination in patients with major depressive disorder",
        "Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)",
        "Opioid modulation with buprenorphine/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial",
        "Evidence for an immune response in major depression: A review and hypothesis",
        "Interleukin-1 beta: A putative mediator of HPA axis hyperactivity in major de-pression?",
        "Sensing damage by the NLRP3 inflammasome",
        "NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder",
        "T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model",
        "The cytokine IL-17A as a marker of treatment resistance in major depressive disor-der?",
        "Differences in the immune-inflammatory profiles of unipolar and bipolar depres-sion",
        "Childhood adversity and current stress are related to pro-and anti-inflammatory cytokines in major depression",
        "MRC immunopsychia-try consortium. Replicable and coupled changes in innate and adaptive immune gene expression in two case-control studies of blood microarrays in major depressive disorder",
        "Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities",
        "Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue",
        "Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs)",
        "T-cell recep-tor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors",
        "NF-\u03baB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene",
        "Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages",
        "Endomorphin-suppressed nitric oxide release from mice peritoneal macrophages",
        "Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors",
        "Nal-buphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis",
        "T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice",
        "Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice",
        "Expression of functional kappa-opioid receptors on murine dendritic cells",
        "Non-peptidic delta-opioid receptor antagonists suppress mitogen-induced tryptophan degradation in peripheral blood mono-nuclear cells in vitro",
        "Spinal interleukin-10 produces antinociception in neuropathy through microglial \u03b2-endorphin ex-pression, separated from antineuroinflammation",
        "Regulation of mu opioid receptor expression in developing T cells",
        "\u00b5 opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes",
        "Upregulation of the nitrosylome in bipolar disorder type 1 (BP1) and major depres-sion, but not BP2: Increased IgM antibodies to nitrosylated conju-gates are associated with indicants of leaky gut",
        "The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased trans-location of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression",
        "Integrating pathophysiology in migraine: role of the gut microbiome and melatonin",
        "Endometriosis pathoetiology and pathophysiology: Roles of vitamin a, estrogen, immunity, adipocytes, gut microbiome and melatonergic pathway on mitochondria regulation",
        "Left ventricular hypertrophy: roles of mitochondria CYP1B1 and melatonergic pathways in co-ordinating wider pathophysiology",
        "Multiple sclerosis, gut mi-crobiota and permeability: role of tryptophan catabolites, depression and the driving down of local melatonin",
        "Multiple sclerosis: melatonin, orexin, and ceramide interact with platelet activation coagulation factors and gut-microbiome-derived butyrate in the circadian dys-regulation of mitochondria in glia and immune cells",
        "Elevated plasma cera-mides in depression",
        "A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major de-pression",
        "Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation",
        "Ganglioside GD3 is required for neurogenesis and long-term maintenance of neural stem cells in the postnatal mouse brain",
        "Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism",
        "The role of the gut microbiome in opioid use",
        "Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS",
        "The opioid system in the gastrointestinal tract",
        "Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome",
        "The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice",
        "Enteric glial-mediated en-hancement of intestinal barrier integrity is compromised by mor-phine",
        "Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4",
        "HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring \u00b5-opioid receptor in spinal cord",
        "The Role of Microbiota in Depression-a brief review",
        "Gut dysbiosis dysregulates central and systemic ho-meostasis via decreased melatonin and suboptimal mitochondria functioning: pathoetiological and pathophysiological implications",
        "Chronic exposure to kappa-opioids enhances the susceptibility of immortalized neurons (F-11kappa 7) to apoptosis-inducing drugs by a mechanism that may involve ceramide",
        "Activities of mitochondrial respiratory chain complexes in platelets of patients with Alz-heimer\u2019s disease and depressive disorder",
        "Cerebral glucose utiliza-tion and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study",
        "Investigation of mito-chondrial DNA copy number in patients with major depressive dis-order",
        "Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson dis-ease",
        "Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression",
        "Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder",
        "The metabolic signature of macrophage responses",
        "Mechanisms involved in phosphatidyli-nositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes",
        "\u00b5-Opioid receptor signalling via PI3K/Akt pathway ameliorates lipopolysaccharide-induced acute respiratory distress syndrome",
        "The protease Omi regulates mitochondrial biogenesis through the GSK3\u03b2/PGC-1\u03b1 pathway",
        "Cellular effects of bu-tyrate on vascular smooth muscle cells are mediated through dispa-rate actions on dual targets, Histone Deacetylase (HDAC) activity and PI3K/Akt signaling network",
        "Butyrate promotes slow-twitch myofi-ber formation and mitochondrial biogenesis in finishing pigs via inducing specific microRNAs and PGC-1\u03b1 expression1",
        "Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats",
        "Upregulation of the kappa opioidergic system in left ventricular rat myocardium in response to volume overload: Adaptive changes of the cardiac kappa opioid system in heart failure",
        "Long-term expression of metabolism-associated genes in the rat hippocampus following re-current neonatal seizures and its regulation by melatonin",
        "Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid",
        "The stimulatory effect of mu-and delta-opioid receptors on bovine pinealocyte melatonin synthesis",
        "Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression-and other conditions character-ized by tryptophan depletion induced by inflammation",
        "Kynurenine pathway metabolites and sui-cidality",
        "Effects of various kynurenine metabolites on respiratory parameters of rat brain, liver and heart mitochondria",
        "Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: me-tabolomics-informed genomics",
        "Inhibition of opioid receptor mediated G-protein activity after chronic administration of kynurenic acid and its derivative without direct binding to opioid receptors",
        "Buprenorphine, norbu-prenorphine, R-Methadone, and S-Methadone upregulate BCRP/ABCG2 expression by activating aryl hydrocarbon receptor in human placental trophoblasts",
        "Constitutive and TCDD-induced expression of Ah receptor-responsive genes in the pituitary",
        "Circadian temperature variation and depressive illness",
        "Diurnal variation: reliability of measurement and relationship to typical and atypical symptoms of depression",
        "Is advancing circadian rhythm the mechanism of antide-pressants?",
        "Immune-pineal axis-acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes",
        "Significant role of gene-gene interactions of clock genes in mood disorder",
        "Interaction of mela-tonin and Bmal1 in the regulation of PI3K/AKT pathway compo-nents and cellular survival",
        "Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with cortisol",
        "Period 2 gene deletion abolishes beta-endorphin neuronal response to ethanol",
        "Distribution and diurnal variations of the mu opioid receptor expression in the arcuate nucleus of the male rat",
        "Rat brain opioid peptides-circadian rhythm is under control of melatonin",
        "The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes",
        "Amygdala real-time functional magnetic resonance imaging neu-rofeedback for major depressive disorder: A review",
        "Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with Major Depressive Disorder symptom severity",
        "Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination",
        "\u201cTop-Down\u201d Mu-opioid system function in humans: Mu-opioid receptors in ventrolateral prefrontal cortex mediate the relationship between hedonic tone and executive function in major depressive disorder",
        "Potential roles for opioid receptors in motivation and major depressive disorder",
        "Mitochondria in developmental and adult neurogenesis",
        "Ly6C(hi) monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis",
        "Circadian clock genes are essential for normal adult neurogenesis, differentiation, and fate determination",
        "Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases",
        "Role of delta-opioid receptor function in neurogenesis and neuroprotection",
        "Effect of delta opioid receptor activation on spatial cognition and neu-rogenesis in cerebral ischemic rats",
        "Mu-and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cul-tures of rat adult hippocampal progenitors",
        "Loss of the mu opioid receptor induces strain-specific alterations in hippocampal neurogenesis and spatial learning",
        "Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation",
        "Reconceptualizing adult neurogenesis: role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions",
        "Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock",
        "Antidepressant Efficacy and Toler-ability of Ketamine and Esketamine: A Critical Review",
        "Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function",
        "Peripheral anti-nociception induced by ketamine is mediated by the endogenous opioid system",
        "Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism",
        "Opioid system is nec-essary but not sufficient for antidepressive actions of ketamine in rodents",
        "ketamine and active ketamine metabolites regulate STAT3 and the type I interferon pathway in human microglia: molecular mechanisms linked to the antidepressant effects of Ketamine",
        "Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappaB, in-terleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines",
        "Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR",
        "Effects of halothane, pen-tobarbital and ketamine on serum melatonin levels in the early sco-tophase in New Zealand white rabbits",
        "Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats",
        "Effects of halothane, ketamine and nitrous oxide on dynorphin mRNA expression in dorsal horn neurons after peripheral tissue in-jury",
        "Day or night administration of ketamine and pentobarbital differentially affect circadian rhythms of pineal melatonin secretion and locomotor activity in rats",
        "Metabolic syndrome rather than body mass index is associated with treatment response to ketamine infusions",
        "The effects of melatonin supplementation on inflammatory markers among patients with metabolic syndrome or related disorders: a systematic review and meta-analysis of randomized controlled trials",
        "Administration of N-acetylserotonin and melatonin alleviate chronic ketamine-induced behavioural phenotype accompanying BDNF-independent and dependent converging cytoprotective mechanisms in the hippo-campus",
        "Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia",
        "Rever-sal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs",
        "Adjuvant effect of melatonin on anesthesia induced by thiopental sodium, ketamine, and ether in rats",
        "Pineal gland abnormality in major depressive disorder",
        "Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression",
        "Are 24-hour motor activity patterns associated with continued rapid response to keta-mine?",
        "The effect of ketamine hydro-chloride, a non-barbiturate parenteral anaesthetic on oxidative phosphorylation in rat liver mitochondria",
        "Stereochemical and structural effects of (2R, 6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells",
        "Ketamine\u2019s antidepressant effect is mediated by energy metabolism and antioxidant de-fense system",
        "Ketamine: a neglected therapy for alzheimer dis-ease",
        "NMDA antagonists for treating the non-motor symptoms in Parkin-son\u2019s disease",
        "Ketamine therapy for treatment-resistant depression in a patient with multiple sclerosis: a case report",
        "Multiple sclerosis: the role of melatonin and N-acetylserotonin",
        "Gut permeability and microbiota in parkinson\u2019s disease: role of depression, tryptophan catabolites, oxidative and nitrosative stress and melaton-ergic pathways",
        "Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders",
        "Venlafaxine prevents morphine antinociceptive tolerance: The role of neuroin-flammation and the l-arginine-nitric oxide pathway",
        "Pharmacological treatments of neuropathic pain: The latest recommendations",
        "Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life",
        "Analgesic adjuvants modulate morphine-induced immune effects in mice",
        "A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression",
        "Exogenous melatonin in the treatment of pain: a systematic review and meta-analysis",
        "Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice",
        "Proenkephalin gene expression in the PC12 pheochromocytoma cell line: stimulation by sodium bu-tyrate",
        "Microbiota dependent production of butyrate is required for the bone anabolic activity of PTH",
        "Inhibition of mitochondrial pyruvate dehydrogenase kinase: a proposed mechanism by which melatonin causes cancer cells to overcome aerobic glycolysis, limit tumor growth and re-verse insensitivity to chemotherapy",
        "Daytime orexin and night-time melatonin regulation of mitochondria melatonin: roles in circadian oscillations systemi-cally and centrally in breast cancer symptomatology",
        "6-Sulfatoxymelatonin predicts treatment response to fluoxetine in major depressive disorder",
        "Serotonin and its metabolites reduce oxidative stress in murine RAW264.7 macrophages and prevent in-flammation",
        "Pin-eal melatonin and the innate immune response: the TNF-alpha increase after cesarean section suppresses nocturnal melatonin pro-duction",
        "Chronic fluoxetine treatment directs energy metabolism towards the citric acid cycle and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria",
        "Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response",
        "NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine",
        "Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor",
        "Health, Aging and Body Composition Study. Mitochondrial DNA m.13514G>A hetero-plasmy is associated with depressive symptoms in the elderly",
        "Genes linking mitochondrial function, cognitive impairment and depression are associated with endophenotypes serving precision medicine",
        "The use and utility of low-dose naltrexone capsules for patients with fibromyalgia",
        "Low-dose naltrexone as a treatment for chronic fatigue syndrome",
        "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants",
        "Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone,immunoglobulin and antibiotic treatment",
        "Ketogenic diet as a metabolic therapy for mood disorders: Evidence and develop-ments",
        "Distinct circadian signatures in liver and gut clocks revealed by ketogenic diet",
        "\u03b2-Hydroxybutyrate elicits favorable mitochondrial changes in skeletal muscle"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "London",
            "@id": "123412614",
            "affilname": "CRC Scotland &amp; London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123412614",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}